IGF2 and colonic neoplasm: However, Kaaks, et al. did not observe an increased risk of colon cancer associated with methylation changes at IGF2 DMR0 when using a more sensitive and quantitative technique (short oligonucleotide mass analysis, SOMA) than classical bisulfite sequencing [27].